Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Review Article

Positron Emission Tomography in Neuroimaging - An Update

Author(s): Xiao-ying Zhang and Pei-ying Zhang*

Volume 13, Issue 2, 2017

Page: [108 - 112] Pages: 5

DOI: 10.2174/1573405612666160816145219

Price: $65

Abstract

Population of aged people is on the rise worldwide, thanks to the advances in medicine, which enhanced lifespan. However, this increased lifespan came with a price, that is, aging associated diseases, of which diseases affecting central nervous system, in particular, stroke, Alzheimer’s disease, Huntington’s disease etc., are predominant. Inasmuch as intervention and access to brain is not always possible by invasive techniques, it is essential to develop non-invasive methods that can give a clue at molecular level regarding the pathological mechanisms in brain regions. Recent advances in neuroradiological and imaging techniques have helped in early and differential diagnosis of several neurological diseases and the underlying molecular mechanisms. Among these, Positron Emission Tomography (PET) holds great promise in the early diagnosis of Alzhemier’s disease, etc. The present review article focuses on the current views, latest developments and reported shortcomings of the versatile imaging technique PET. An important aspect of PET is the specificity of neuroimaging agents, as these often have undesirably high non-specific binding to brain tissue and we address this and discuss the recent advances in the development of these agents as well as the specific biomarkers for neuroimaging.

Keywords: Alzheimer's disease, centiloid scale, equilibrium dialysis, non-specific binding, PET tracer, tissue distribution.

Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy